Metraipolis › archive › dc_84d11d27fa92

Research Communication: Serum Metabolomic Signatures Predict Tumour Recurrence After Resection or Ablation in Patients With Early-Stage Hepatocellular Carcinoma — Europe PMC PMID:40875577

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40875577
DOI
10.1111/apt.70355
License (as archived)
solo-consultazione
Archived
2026-11-10T08:55:01.341Z
SHA-256 of the archived text
dd15652a70ec48d50f9da39acd44d21a3c6d4180c7ff9e4c9f37a1db1515adb7
Stable URL of this page
https://metraipolis.com/documento/dc_84d11d27fa92

How to cite

Research Communication: Serum Metabolomic Signatures Predict Tumour Recurrence After Resection or Ablation in Patients With Early-Stage Hepatocellular Carcinoma — Europe PMC PMID:40875577 — Europe PMC (en), https://europepmc.org/article/MED/40875577 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_84d11d27fa92 (Metraipolis archive dc_84d11d27fa92, sha256 dd15652a70ec48d50f9da39acd44d21a3c6d4180c7ff9e4c9f37a1db1515adb7)
BibTeX
@misc{dc84d11d27fa92,
  title = {Research Communication: Serum Metabolomic Signatures Predict Tumour Recurrence After Resection or Ablation in Patients With Early-Stage Hepatocellular Carcinoma — Europe PMC PMID:40875577},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40875577},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_84d11d27fa92; sha256 dd15652a70ec48d50f9da39acd44d21a3c6d4180c7ff9e4c9f37a1db1515adb7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40875577. Agents can read the archived copy with the MCP tool read_document.